Keyphrases
5-bisphosphate
100%
Active Metabolite
7%
Antineoplastic Agents
7%
Cancer Patients
7%
Cellular Components
7%
Continuous Infusion
7%
Cytosine
100%
Dose-ranging
7%
High-performance Liquid Chromatography
100%
Human Tumors
7%
Incubation
7%
Investigational Drugs
7%
Ion Pairs
7%
Limit of Quantification
7%
MOLT-4
7%
Murine Tumors
7%
Nucleoside Analogues
7%
Peripheral Blood Mononuclear Cells
21%
Phase I Clinical Trial
7%
Plasma Parameters
7%
Programmable Switching
7%
Radiolabeled Drug
7%
Retention Mechanism
7%
Reversed-phase Column
7%
Switching Valve
7%
T Cell Lines
7%
T Cells
7%
Tissue Culture
14%
Neuroscience
1 (4,5 Dihydroxy 3 Hydroxymethyl 2 Cyclopenten 1 Yl)cytosine
100%
Anticarcinogen
7%
Cell Line
7%
In Vitro
100%
In Vivo
100%
Nucleoside Analog
7%
Peripheral Blood Mononuclear Cell
21%
T Cell
7%
Chemistry
Antineoplastic
7%
Cytosine
100%
High-Pressure Liquid Chromatography
100%
Metabolite
7%
Nucleoside Analogue
7%
Plasma Level
7%
Triphosphate(5-)
100%
Pharmacology, Toxicology and Pharmaceutical Science
1 (4,5 Dihydroxy 3 Hydroxymethyl 2 Cyclopenten 1 Yl)cytosine
100%
Active Metabolite
7%
Anticarcinogen
7%
Clinical Trial
7%
High Performance Liquid Chromatography
100%
Investigational Drug
7%
Malignant Neoplasm
7%
Neoplasm
7%
Nucleoside Analog
7%